The impact of mood disorders and their treatment on the pregnant woman, the fetus, and the infant.
Kloos AL, Dubin-Rhodin A, Sackett JC, Dixon TA, Weller RA, Weller EB
Department of Child and Adolescent Psychiatry, Children's National Medical Center, 111 Michigan Avenue, NW, Suite 1200, Washington, DC 20010, USA. akloos@cnmc.org
Treatment of mood disorders in pregnant or nursing women can carry significant risks for the mother and the developing infant. For patients and physicians, it may be difficult to obtain current information to make the proper decisions regarding pharmacologic and alternative treatments. Thus, this paper discusses the risks and benefits of pharmacologic treatment and the risks of not treating depression and bipolar disorder in the pregnant woman. The safety of treatment options is reviewed. Alternative treatment options are also discussed.
Published 28 April 2010 in Curr Psychiatry Rep, 12(2): 96-103.
Full-text of this article is available online (may require subscription).
© 2004-2013 Bipolar Research Today. All Rights Reserved.
| 
